Literature DB >> 11583806

The nigrostriatal dopamine system: a neglected target for 5-HT2C receptors.

P De Deurwaerdère, U Spampinato.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583806     DOI: 10.1016/s0165-6147(00)01811-3

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  8 in total

1.  5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease.

Authors:  Marcus C Ferguson; Tultul Nayyar; Ariel Y Deutch; Twum A Ansah
Journal:  Neuropharmacology       Date:  2010-03-31       Impact factor: 5.250

2.  Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.

Authors:  Mark J Millan; Sylvie Veiga; Sylvie Girardon; Mauricette Brocco
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

3.  Stimulation of serotonin2C receptors influences cocaine-seeking behavior in response to drug-associated stimuli in rats.

Authors:  Silvia Burbassi; Luigi Cervo
Journal:  Psychopharmacology (Berl)       Date:  2007-09-27       Impact factor: 4.530

4.  Pupillography as a sensitive, noninvasive biomarker in healthy volunteers: first-in-man study of BAY 63-9044, a new 5-HT1A-receptor agonist with dopamine agonistic properties.

Authors:  Georg Wensing; Claus Haase; Erich Brendel; Michael Friedrich Böttcher
Journal:  Eur J Clin Pharmacol       Date:  2007-09-25       Impact factor: 2.953

5.  Role of 5-HT2C receptors in the enhancement of c-Fos expression induced by a 5-HT2B/2C inverse agonist and 5-HT 2 agonists in the rat basal ganglia.

Authors:  S Navailles; M Lagière; C Le Moine; P De Deurwaerdère
Journal:  Exp Brain Res       Date:  2013-05-17       Impact factor: 1.972

6.  S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.

Authors:  Anne Dekeyne; Clotilde Mannoury la Cour; Alain Gobert; Mauricette Brocco; Françoise Lejeune; Florence Serres; Trevor Sharp; Annie Daszuta; Amélie Soumier; Mariusz Papp; Jean-Michel Rivet; Gunnar Flik; Thomas I Cremers; Olivier Muller; Gilbert Lavielle; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2008-06-04       Impact factor: 4.530

Review 7.  Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications.

Authors:  Kelly A Berg; William P Clarke; Kathryn A Cunningham; Umberto Spampinato
Journal:  Neuropharmacology       Date:  2008-06-17       Impact factor: 5.250

8.  Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity.

Authors:  Przemyslaw Nowak; Aleksandra Bortel; Joanna Dabrowska; Joanna Oswiecimska; Marzena Drosik; Adam Kwiecinski; Józef Opara; Richard M Kostrzewa; Ryszard Brus
Journal:  Neurotox Res       Date:  2007-02       Impact factor: 3.911

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.